• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对一种外显子跳跃治疗方法进行基因建模的小鼠中的持续性CLN3型巴滕病

Protracted CLN3 Batten disease in mice that genetically model an exon-skipping therapeutic approach.

作者信息

Centa Jessica L, Stratton Matthew P, Pratt Melissa A, Osterlund Oltmanns Jenna R, Wallace Douglas G, Miller Steven A, Weimer Jill M, Hastings Michelle L

机构信息

Center for Genetic Diseases, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA.

School of Graduate and Postdoctoral Studies, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA.

出版信息

Mol Ther Nucleic Acids. 2023 Jun 3;33:15-27. doi: 10.1016/j.omtn.2023.05.025. eCollection 2023 Sep 12.

DOI:10.1016/j.omtn.2023.05.025
PMID:37359347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10285469/
Abstract

Genetic mutations that disrupt open reading frames and cause translation termination are frequent causes of human disease and are difficult to treat due to protein truncation and mRNA degradation by nonsense-mediated decay, leaving few options for traditional drug targeting. Splice-switching antisense oligonucleotides offer a potential therapeutic solution for diseases caused by disrupted open reading frames by inducing exon skipping to correct the open reading frame. We have recently reported on an exon-skipping antisense oligonucleotide that has a therapeutic effect in a mouse model of CLN3 Batten disease, a fatal pediatric lysosomal storage disease. To validate this therapeutic approach, we generated a mouse model that constitutively expresses the spliced isoform induced by the antisense molecule. Behavioral and pathological analyses of these mice demonstrate a less severe phenotype compared with the CLN3 disease mouse model, providing evidence that antisense oligonucleotide-induced exon skipping can have therapeutic efficacy in treating CLN3 Batten disease. This model highlights how protein engineering through RNA splicing modulation can be an effective therapeutic approach.

摘要

破坏开放阅读框并导致翻译终止的基因突变是人类疾病的常见病因,由于蛋白质截短和无义介导的衰变导致mRNA降解,难以治疗,传统药物靶向几乎没有选择。剪接转换反义寡核苷酸通过诱导外显子跳跃来纠正开放阅读框,为因开放阅读框破坏引起的疾病提供了一种潜在的治疗方案。我们最近报道了一种外显子跳跃反义寡核苷酸,它在CLN3型巴滕病(一种致命的儿童溶酶体贮积病)的小鼠模型中具有治疗作用。为了验证这种治疗方法,我们构建了一个组成性表达由反义分子诱导的剪接异构体的小鼠模型。对这些小鼠的行为和病理分析表明,与CLN3疾病小鼠模型相比,其表型较轻,这证明反义寡核苷酸诱导的外显子跳跃在治疗CLN3型巴滕病方面具有治疗效果。该模型突出了通过RNA剪接调控进行蛋白质工程如何能够成为一种有效的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/209a/10285469/9121e43a6185/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/209a/10285469/03020869977a/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/209a/10285469/5508790bbd2d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/209a/10285469/7d6831811ab7/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/209a/10285469/719eba50859c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/209a/10285469/a9c4d58433e4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/209a/10285469/5d9e155ac846/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/209a/10285469/9121e43a6185/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/209a/10285469/03020869977a/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/209a/10285469/5508790bbd2d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/209a/10285469/7d6831811ab7/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/209a/10285469/719eba50859c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/209a/10285469/a9c4d58433e4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/209a/10285469/5d9e155ac846/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/209a/10285469/9121e43a6185/gr6.jpg

相似文献

1
Protracted CLN3 Batten disease in mice that genetically model an exon-skipping therapeutic approach.对一种外显子跳跃治疗方法进行基因建模的小鼠中的持续性CLN3型巴滕病
Mol Ther Nucleic Acids. 2023 Jun 3;33:15-27. doi: 10.1016/j.omtn.2023.05.025. eCollection 2023 Sep 12.
2
Therapeutic efficacy of antisense oligonucleotides in mouse models of CLN3 Batten disease.抗反义寡核苷酸在 CLN3 神经鞘脂贮积症小鼠模型中的治疗效果。
Nat Med. 2020 Sep;26(9):1444-1451. doi: 10.1038/s41591-020-0986-1. Epub 2020 Jul 27.
3
A Precision Therapy Approach for Retinitis Pigmentosa 11 Using Splice-Switching Antisense Oligonucleotides to Restore the Open Reading Frame of PRPF31.使用剪接转换反义寡核苷酸恢复 PRPF31 开放阅读框的视网膜色素变性 11 的精准治疗方法。
Int J Mol Sci. 2024 Mar 16;25(6):3391. doi: 10.3390/ijms25063391.
4
Target selection for antisense oligonucleotide induced exon skipping in the dystrophin gene.抗肌萎缩蛋白基因中反义寡核苷酸诱导外显子跳跃的靶点选择
J Gene Med. 2003 Jun;5(6):518-27. doi: 10.1002/jgm.361.
5
Open reading frame correction using splice-switching antisense oligonucleotides for the treatment of cystic fibrosis.使用剪接转换反义寡核苷酸进行开放阅读框校正治疗囊性纤维化。
Proc Natl Acad Sci U S A. 2022 Jan 18;119(3). doi: 10.1073/pnas.2114886119.
6
Designing Effective Antisense Oligonucleotides for Exon Skipping.设计用于外显子跳跃的有效反义寡核苷酸
Methods Mol Biol. 2018;1687:143-155. doi: 10.1007/978-1-4939-7374-3_10.
7
Tips to Design Effective Splice-Switching Antisense Oligonucleotides for Exon Skipping and Exon Inclusion.设计用于外显子跳跃和外显子包含的有效剪接转换反义寡核苷酸的技巧。
Methods Mol Biol. 2018;1828:79-90. doi: 10.1007/978-1-4939-8651-4_5.
8
Exon-skipping antisense oligonucleotides for cystic fibrosis therapy.用于囊性纤维化治疗的外显子跳跃反义寡核苷酸。
Proc Natl Acad Sci U S A. 2022 Jan 18;119(3). doi: 10.1073/pnas.2114858118.
9
Engineering exon-skipping vectors expressing U7 snRNA constructs for Duchenne muscular dystrophy gene therapy.构建用于杜氏肌营养不良基因治疗的表达U7小核RNA构建体的外显子跳跃载体。
Methods Mol Biol. 2011;709:179-96. doi: 10.1007/978-1-61737-982-6_11.
10
Antisense-Mediated Splice Modulation to Reframe Transcripts.反义介导的剪接调控以重新构建转录本。
Methods Mol Biol. 2018;1828:531-552. doi: 10.1007/978-1-4939-8651-4_35.

引用本文的文献

1
Tailored antisense oligonucleotides for ultrarare CNS diseases: An experience-based best practice framework for individual patient evaluation.针对超罕见中枢神经系统疾病的定制反义寡核苷酸:基于经验的个体患者评估最佳实践框架。
Mol Ther Nucleic Acids. 2025 Jul 1;36(3):102615. doi: 10.1016/j.omtn.2025.102615. eCollection 2025 Sep 9.
2
Therapeutic antisense oligonucleotide mitigates retinal dysfunction in a pig model of CLN3 Batten disease.治疗性反义寡核苷酸可减轻CLN3型巴滕病猪模型中的视网膜功能障碍。
bioRxiv. 2025 May 31:2025.05.30.656864. doi: 10.1101/2025.05.30.656864.
3
Neuronal Ceroid Lipofuscinosis-Concepts, Classification, and Avenues for Therapy.

本文引用的文献

1
Activation of PPARα Exhibits Therapeutic Efficacy in a Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis.PPARα 的激活在幼年神经细胞蜡样质脂褐质沉积症的小鼠模型中表现出治疗效果。
J Neurosci. 2023 Mar 8;43(10):1814-1829. doi: 10.1523/JNEUROSCI.2447-21.2023. Epub 2023 Jan 25.
2
Sex-split analysis of pathology and motor-behavioral outcomes in a mouse model of CLN8-Batten disease reveals an increased disease burden and trajectory in female Cln8 mice.CLN8 脑苷脂沉积病小鼠模型的病理学和运动行为结果的性别分离分析显示雌性 Cln8 小鼠的疾病负担和病程增加。
Orphanet J Rare Dis. 2022 Nov 11;17(1):411. doi: 10.1186/s13023-022-02564-7.
3
神经元蜡样脂褐质沉积症——概念、分类及治疗途径
CNS Neurosci Ther. 2025 Feb;31(2):e70261. doi: 10.1111/cns.70261.
4
Systematic deletion of symmetrical exons reveals new therapeutic targets for exon skipping antisense oligonucleotides.对称外显子的系统性缺失揭示了外显子跳跃反义寡核苷酸的新治疗靶点。
NAR Mol Med. 2024 Nov 6;1(4):ugae017. doi: 10.1093/narmme/ugae017. eCollection 2024 Oct.
5
CLN3 transcript complexity revealed by long-read RNA sequencing analysis.长读 RNA 测序分析揭示 CLN3 转录本的复杂性。
BMC Med Genomics. 2024 Oct 4;17(1):244. doi: 10.1186/s12920-024-02017-z.
6
Splice-switching antisense oligonucleotides for pediatric neurological disorders.用于小儿神经疾病的剪接转换反义寡核苷酸
Front Mol Neurosci. 2024 Jul 25;17:1412964. doi: 10.3389/fnmol.2024.1412964. eCollection 2024.
7
Preparing for Patient-Customized N-of-1 Antisense Oligonucleotide Therapy to Treat Rare Diseases.为治疗罕见病的患者定制的 N-of-1 反义寡核苷酸治疗做准备。
Genes (Basel). 2024 Jun 21;15(7):821. doi: 10.3390/genes15070821.
8
Loss of the lysosomal protein CLN3 modifies the lipid content of the nuclear envelope leading to DNA damage and activation of YAP1 pro-apoptotic signaling.溶酶体蛋白CLN3的缺失会改变核膜的脂质成分,导致DNA损伤并激活YAP1促凋亡信号。
bioRxiv. 2024 Jun 2:2024.05.31.596474. doi: 10.1101/2024.05.31.596474.
9
Drug Repurposing and Lysosomal Storage Disorders: A Trick to Treat.药物重定位与溶酶体贮积症:治疗的新策略
Genes (Basel). 2024 Feb 25;15(3):290. doi: 10.3390/genes15030290.
10
Domain-inlaid Nme2Cas9 adenine base editors with improved activity and targeting scope.域镶嵌的 Nme2Cas9 腺嘌呤碱基编辑器,活性和靶向范围提高。
Nat Commun. 2024 Feb 17;15(1):1458. doi: 10.1038/s41467-024-45763-5.
The physiology of alternative splicing.
可变剪接的生理学
Nat Rev Mol Cell Biol. 2023 Apr;24(4):242-254. doi: 10.1038/s41580-022-00545-z. Epub 2022 Oct 13.
4
Associations Between Handgrip Strength and Dementia Risk, Cognition, and Neuroimaging Outcomes in the UK Biobank Cohort Study.英国生物库队列研究中握力与痴呆风险、认知和神经影像学结果的相关性。
JAMA Netw Open. 2022 Jun 1;5(6):e2218314. doi: 10.1001/jamanetworkopen.2022.18314.
5
Towards Understanding Behaviour and Emotions of Children with CLN3 Disease (Batten Disease): Patterns, Problems and Support for Child and Family.了解 CLN3 病(Batten 病)儿童的行为和情绪:儿童和家庭的模式、问题和支持。
Int J Environ Res Public Health. 2022 May 12;19(10):5895. doi: 10.3390/ijerph19105895.
6
Characterization of neurological disease progression in a canine model of CLN5 neuronal ceroid lipofuscinosis.CLN5 神经元蜡样脂褐质沉积症犬模型中神经退行性疾病进展的特征。
Dev Neurobiol. 2022 May;82(4):326-344. doi: 10.1002/dneu.22878. Epub 2022 Apr 28.
7
Evaluation of DNA segments in 2'-modified RNA sequences in designing efficient splice switching antisense oligonucleotides.在设计高效剪接转换反义寡核苷酸时对2'-修饰RNA序列中的DNA片段进行评估。
RSC Adv. 2021 Apr 13;11(23):14029-14035. doi: 10.1039/d1ra00878a.
8
Consensus Paper: Ataxic Gait.共识文件:共济失调步态。
Cerebellum. 2023 Jun;22(3):394-430. doi: 10.1007/s12311-022-01373-9. Epub 2022 Apr 12.
9
Neuronal genetic rescue normalizes brain network dynamics in a lysosomal storage disorder despite persistent storage accumulation.神经元基因治疗可纠正溶酶体贮积症的脑网络动态,尽管持续存在贮积物积累。
Mol Ther. 2022 Jul 6;30(7):2464-2473. doi: 10.1016/j.ymthe.2022.03.025. Epub 2022 Apr 5.
10
A Link between Handgrip Strength and Executive Functioning: A Cross-Sectional Study in Older Adults with Mild Cognitive Impairment and Healthy Controls.握力与执行功能之间的联系:一项针对轻度认知障碍老年人和健康对照者的横断面研究。
Healthcare (Basel). 2022 Jan 26;10(2):230. doi: 10.3390/healthcare10020230.